BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32845968)

  • 21. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study.
    Belalcazar LM; Reboussin DM; Haffner SM; Hoogeveen RC; Kriska AM; Schwenke DC; Tracy RP; Pi-Sunyer FX; Ballantyne CM;
    Diabetes Care; 2010 Nov; 33(11):2297-303. PubMed ID: 20682679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
    ; Pi-Sunyer X; Blackburn G; Brancati FL; Bray GA; Bright R; Clark JM; Curtis JM; Espeland MA; Foreyt JP; Graves K; Haffner SM; Harrison B; Hill JO; Horton ES; Jakicic J; Jeffery RW; Johnson KC; Kahn S; Kelley DE; Kitabchi AE; Knowler WC; Lewis CE; Maschak-Carey BJ; Montgomery B; Nathan DM; Patricio J; Peters A; Redmon JB; Reeves RS; Ryan DH; Safford M; Van Dorsten B; Wadden TA; Wagenknecht L; Wesche-Thobaben J; Wing RR; Yanovski SZ
    Diabetes Care; 2007 Jun; 30(6):1374-83. PubMed ID: 17363746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.
    Look AHEAD Research Group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):801-9. PubMed ID: 25127483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Longitudinal Glucose Exposure on Cognitive and Physical Function: Results from the Action for Health in Diabetes Movement and Memory Study.
    Beavers KM; Leng I; Rapp SR; Miller ME; Houston DK; Marsh AP; Hire DG; Baker LD; Bray GA; Blackburn GL; Hergenroeder AL; Jakicic JM; Johnson KC; Korytkowski MT; Dorsten BV; Kritchevsky SB;
    J Am Geriatr Soc; 2017 Jan; 65(1):137-145. PubMed ID: 27676466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the Intensive Lifestyle Intervention With Total Knee Replacement in the Look AHEAD (Action for Health in Diabetes) Clinical Trial.
    Richey PA; Johnson KC; Neiberg RH; Bahnson JL; Singhal K; Coday M; Thomas F; Lewis CE; Mihalko WM;
    J Arthroplasty; 2020 Jun; 35(6):1576-1582. PubMed ID: 32085906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study.
    Gregg EW; Lin J; Bardenheier B; Chen H; Rejeski WJ; Zhuo X; Hergenroeder AL; Kritchevsky SB; Peters AL; Wagenknecht LE; Ip EH; Espeland MA;
    Diabetes Care; 2018 May; 41(5):1040-1048. PubMed ID: 29545462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.
    Look AHEAD Research Group
    Diabetologia; 2015 Aug; 58(8):1803-13. PubMed ID: 25972230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of an intensive lifestyle intervention with remission of type 2 diabetes.
    Gregg EW; Chen H; Wagenknecht LE; Clark JM; Delahanty LM; Bantle J; Pownall HJ; Johnson KC; Safford MM; Kitabchi AE; Pi-Sunyer FX; Wing RR; Bertoni AG;
    JAMA; 2012 Dec; 308(23):2489-96. PubMed ID: 23288372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four-year change in cardiorespiratory fitness and influence on glycemic control in adults with type 2 diabetes in a randomized trial: the Look AHEAD Trial.
    Jakicic JM; Egan CM; Fabricatore AN; Gaussoin SA; Glasser SP; Hesson LA; Knowler WC; Lang W; Regensteiner JG; Ribisl PM; Ryan DH;
    Diabetes Care; 2013 May; 36(5):1297-303. PubMed ID: 23223405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep architecture following a weight loss intervention in overweight and obese patients with obstructive sleep apnea and type 2 diabetes: relationship to apnea-hypopnea index.
    Shechter A; St-Onge MP; Kuna ST; Zammit G; RoyChoudhury A; Newman AB; Millman RP; Reboussin DM; Wadden TA; Jakicic JM; Pi-Sunyer FX; Wing RR; Foster GD;
    J Clin Sleep Med; 2014 Nov; 10(11):1205-11. PubMed ID: 25325608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: results from the Look AHEAD trial.
    Gorin AA; Niemeier HM; Hogan P; Coday M; Davis C; DiLillo VG; Gluck ME; Wadden TA; West DS; Williamson D; Yanovski SZ;
    Arch Gen Psychiatry; 2008 Dec; 65(12):1447-55. PubMed ID: 19047532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD.
    Belalcazar LM; Lang W; Haffner SM; Schwenke DC; Kriska A; Balasubramanyam A; Hoogeveen RC; Pi-Sunyer FX; Tracy RP; Ballantyne CM;
    Diabetes Care; 2015 Aug; 38(8):1544-50. PubMed ID: 25972574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 Diabetes Subgroups, Risk for Complications, and Differential Effects Due to an Intensive Lifestyle Intervention.
    Bancks MP; Chen H; Balasubramanyam A; Bertoni AG; Espeland MA; Kahn SE; Pilla S; Vaughan E; Wagenknecht LE;
    Diabetes Care; 2021 May; 44(5):1203-1210. PubMed ID: 33707304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Long-Term Dietary Fat Intake, Exercise, and Weight with Later Cognitive Function in the Finnish Diabetes Prevention Study.
    Lehtisalo J; Lindström J; Ngandu T; Kivipelto M; Ahtiluoto S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Eriksson JG; Uusitupa M; Tuomilehto J; Luchsinger J;
    J Nutr Health Aging; 2016 Feb; 20(2):146-54. PubMed ID: 26812510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment.
    Espeland MA; Luchsinger JA; Baker LD; Neiberg R; Kahn SE; Arnold SE; Wing RR; Blackburn GL; Bray G; Evans M; Hazuda HP; Jeffery RW; Wilson VM; Clark JM; Coday M; Demos-McDermott K; Foreyt JP; Greenway F; Hill JO; Horton ES; Jakicic JM; Johnson KC; Knowler WC; Lewis CE; Nathan DM; Peters A; Pi-Sunyer X; Pownall H; Wadden TA; Rapp SR;
    Neurology; 2017 May; 88(21):2026-2035. PubMed ID: 28446656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of visceral adipose tissue reduction on CVD risk factors independent of weight loss: The Look AHEAD study.
    Sanguankeo A; Lazo M; Upala S; Brancati FL; Bonekamp S; Pownall HJ; Balasubramanyam A; Clark JM;
    Endocr Res; 2017 May; 42(2):86-95. PubMed ID: 27351077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial.
    Knowler WC; Chen H; Bahnson JL; Kahn SE; Lewis CE; Nathan DM; Nelson RG; Pilla SJ; Bantle JP;
    BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38816203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention.
    Rejeski WJ; Bray GA; Chen SH; Clark JM; Evans M; Hill JO; Jakicic JM; Johnson KC; Neiberg R; Ip EH;
    J Gerontol A Biol Sci Med Sci; 2015 Mar; 70(3):345-53. PubMed ID: 24986062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body image changes associated with participation in an intensive lifestyle weight loss intervention.
    Stewart TM; Bachand AR; Han H; Ryan DH; Bray GA; Williamson DA
    Obesity (Silver Spring); 2011 Jun; 19(6):1290-5. PubMed ID: 21151020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
    Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.